D.E. Shaw & Co’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-61,100
Closed -$2.93M 4047
2019
Q3
$2.93M Buy
61,100
+50,000
+450% +$2.61M ﹤0.01% 2068
2019
Q2
$741K Buy
+11,100
New +$845K ﹤0.01% 2858
2019
Q1
Sell
-15,000
Closed -$1.86M 3741
2018
Q4
$1.86M Sell
15,000
-9,700
-39% -$1.6M ﹤0.01% 2219
2018
Q3
$6.03M Buy
+24,700
New +$5.71M 0.01% 1450

Other funds holding INGN

D.E. Shaw & Co's INGN Position: Q1 2026 in Review

D.E. Shaw & Co opened a new position in Inogen (INGN) in Q1 2026: 46,643 shares worth $288K. The stake represents ﹤0.01% of the portfolio and ranks #4087 among its holdings. This is a return to the name: D.E. Shaw & Co previously reported a position in INGN as recently as Q4 2024.

D.E. Shaw & Co first reported a position in INGN in Q1 2015 and has held it in 25 quarters since. The position peaked at $24.9M in Q4 2019. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.

  • D.E. Shaw & Co held 46,643 shares of Inogen worth $288K as of Q1 2026.
  • Inogen was a new D.E. Shaw & Co position in Q1 2026.
  • Inogen made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4087 holding.
  • D.E. Shaw & Co first reported a position in Inogen in Q1 2015 and has held it in 25 quarters since.
  • D.E. Shaw & Co's Inogen position peaked at $24.9M in Q4 2019.
  • 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.